Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study
Diagnostics · 07.07.2023 · 13 (13) · 2306
DOI: 10.3390/diagnostics13132306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 07.07.2023. Verfasst von Geovana M Pereira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: bioMérieux.
Abstract (Originalsprache)
Chikungunya (CHIK) is a debilitating mosquito-borne disease with an epidemiology and early clinical symptoms similar to those of other arboviruses-triggered diseases such as dengue or Zika. Accurate and rapid diagnosis of CHIK virus (CHIKV) infection is therefore challenging. This international study evaluated the performance of the automated VIDAS® anti-CHIKV IgM and IgG assays compared to that of manual competitor IgM and IgG ELISA for the detection of anti-CHIKV IgM and IgG antibodies in 660 patients with suspected CHIKV infection. Positive and negative agreements of the VIDAS® CHIKV assays with ELISA ranged from 97.5% to 100.0%. The sensitivity of the VIDAS® CHIKV assays evaluated in patients with a proven CHIKV infection confirmed reported kinetics of anti-CHIKV IgM and IgG response, with a positive detection of 88.2–100.0% for IgM ≥ 5 days post symptom onset and of 100.0% for IgG ≥ 11 days post symptom onset. Our study also demonstrated the superiority of ELISA and VIDAS® assays over rapid diagnostic IgM/IgG tests. The analytical performance of VIDAS® anti-CHIKV IgM and IgG assays was excellent, with a high precision (coefficients of variation ≤ 7.4%) and high specificity (cross-reactivity rate ≤ 2.9%). This study demonstrates the suitability of the automated VIDAS® anti-CHIKV IgM and IgG assays to diagnose CHIKV infections and supports its applicability for epidemiological surveillance and differential diagnosis in regions endemic for CHIKV.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil.
- Faculdade de Medicina da Universidade Municipal de São Caetano do Sul, São Paulo 09521-160, Brazil.
- Laboratório de Investigação Médica/Parasitologia LIM/46, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, Brazil.
- bioMérieux, 69280 Marcy l'Etoile, France.
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-010, Brazil.
- Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.
ORCID-Profile: Glaucia Paranhos-Baccalà
Förderung
- bioMérieux
Zitieren
APA
Pereira, G. M., Manuli, E. R., Coulon, L., Côrtes, M. F., Ramundo, M. S., Dromenq, L., Larue-Triolet, A., Raymond, F., Tourneur, C., Lázari, C. D. S., Brasil, P., Filippis, A. M. B., Paranhos-Baccalà, G., Banz, A., & Sabino, E. C. (2023). Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study. Diagnostics, 13(13), 2306. https://doi.org/10.3390/diagnostics13132306
Vancouver
Pereira GM, Manuli ER, Coulon L, Côrtes MF, Ramundo MS, Dromenq L, et al. Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study. Diagnostics. 2023;13(13):2306. doi:10.3390/diagnostics13132306
BibTeX
@article{Pereira2023,
author = {Pereira, Geovana M and Manuli, Erika R and Coulon, Laurie and Côrtes, Marina F and Ramundo, Mariana S and Dromenq, Loïc and Larue-Triolet, Audrey and Raymond, Frédérique and Tourneur, Carole and Lázari, Carolina Dos Santos and Brasil, Patricia and Filippis, Ana Maria Bispo de and Paranhos-Baccalà, Glaucia and Banz, Alice and Sabino, Ester C},
title = {Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {13},
pages = {2306},
doi = {10.3390/diagnostics13132306}
}
EUVIMED